186 related articles for article (PubMed ID: 36115317)
1. Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
Douschan P; Kovacs G; Sassmann T; Stadlbauer V; Avian A; Foris V; Tatscher E; Durchschein F; Rainer F; Spindelboeck W; Wagner M; Kniepeiss D; Zollner G; Bachmaier G; Fickert P; Olschewski H; Stauber RE
Respir Med; 2022 Oct; 202():106987. PubMed ID: 36115317
[TBL] [Abstract][Full Text] [Related]
2. [Liver diseases and pulmonary vascular disorders].
Riou M; Jutant EM; Mignard X; Canuet M; Humbert M; Sitbon O; Savale L; Montani D
Rev Med Interne; 2018 Dec; 39(12):925-934. PubMed ID: 30174113
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vascular abnormalities in cirrhosis.
Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary complications of cirrhosis.
Kochar R; Nevah Rubin MI; Fallon MB
Curr Gastroenterol Rep; 2011 Feb; 13(1):34-9. PubMed ID: 21125431
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension.
Raevens S; Geerts A; Devisscher L; Van Vlierberghe H; Van Steenkiste C; Colle I
Acta Gastroenterol Belg; 2021; 84(1):95-99. PubMed ID: 33639700
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary complication of liver disease].
Dollinger MM
Praxis (Bern 1994); 2006 Oct; 95(40):1539-42. PubMed ID: 17048411
[TBL] [Abstract][Full Text] [Related]
7. Serum Oxidative/anti-oxidative Stress Balance Is Dysregulated in Potentially Pulmonary Hypertensive Patients with Liver Cirrhosis: A Case Control Study.
Terao M; Takaki A; Maruyama T; Oe H; Yasunaka T; Tamaki N; Nakamura K; Tomofuji T; Yagi T; Sadamori H; Umeda Y; Shinoura S; Yoshida R; Nouso K; Ekuni D; Koike K; Ikeda F; Shiraha H; Morita M; Ito H; Fujiwara T; Yamamoto K
Intern Med; 2015; 54(22):2815-26. PubMed ID: 26567993
[TBL] [Abstract][Full Text] [Related]
8. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Pulmonary Vascular Complications of Liver Disease.
Del Valle K; DuBrock HM
Compr Physiol; 2021 Oct; 11(4):3281-3302. PubMed ID: 34636408
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options in pulmonary hepatic vascular diseases.
Horvatits T; Fuhrmann V
Expert Rev Clin Pharmacol; 2014 Jan; 7(1):31-42. PubMed ID: 24308785
[TBL] [Abstract][Full Text] [Related]
10. Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review.
Li N; Wu Q; Meng J; Feng C; Jiang S; Chen M; Xu W; Wang F; Zhang Y; Liu J; Xu C; Liu G; Gao H
ESC Heart Fail; 2023 Aug; 10(4):2718-2721. PubMed ID: 37313579
[TBL] [Abstract][Full Text] [Related]
11. Onset ages of hepatopulmonary syndrome and pulmonary hypertension in patients with biliary atresia.
Ueno T; Saka R; Takama Y; Yamanaka H; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2017 Oct; 33(10):1053-1057. PubMed ID: 28871319
[TBL] [Abstract][Full Text] [Related]
12. Hepatopulmonary syndrome: prevalence and predictors in Egyptian cirrhotic patients.
El Makarem MA; Elakad A; Ali A; Abd-Elkader M; Sayed AF; Taha A; Abd-Elrhman T
Trop Gastroenterol; 2011; 32(1):25-30. PubMed ID: 21922852
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary complications in liver diseases].
Horvatits T; Drolz A; Rutter K; Kluge S; Fuhrmann V
Med Klin Intensivmed Notfmed; 2014 May; 109(4):235-9. PubMed ID: 24763525
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of severe hepatopulmonary syndrome with a sequential use of TIPS placement and liver transplantation.
Benítez C; Arrese M; Jorquera J; Godoy I; Contreras A; Loyola S; Domínguez P; Jarufe N; Martínez J; Pérez-Ayuso RM
Ann Hepatol; 2009; 8(1):71-4. PubMed ID: 19221539
[TBL] [Abstract][Full Text] [Related]
15. [Hepatopulmonary syndrome].
Sayadi A; Duhaut L; Robert F; Savale L; Coilly A
Rev Med Interne; 2024 Mar; 45(3):156-165. PubMed ID: 37005097
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].
Herzer K; Post F; Canbay A; Gerken G
Med Klin (Munich); 2010 Dec; 105(12):916-23. PubMed ID: 21240591
[TBL] [Abstract][Full Text] [Related]
17. A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation.
Saragai Y; Takaki A; Umeda Y; Matsusaki T; Yasunaka T; Oyama A; Kaku R; Nakamura K; Yoshida R; Nobuoka D; Kuise T; Takagi K; Adachi T; Wada N; Takeuchi Y; Koike K; Ikeda F; Onishi H; Shiraha H; Nakamura S; Morimatsu H; Ito H; Fujiwara T; Yagi T; Okada H
BMC Gastroenterol; 2018 May; 18(1):62. PubMed ID: 29764373
[TBL] [Abstract][Full Text] [Related]
18. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.
Porres-Aguilar M; Altamirano JT; Torre-Delgadillo A; Charlton MR; Duarte-Rojo A
Eur Respir Rev; 2012 Sep; 21(125):223-33. PubMed ID: 22941887
[TBL] [Abstract][Full Text] [Related]
19. Hepatopulmonary syndrome in children with cirrhotic and non-cirrhotic portal hypertension: a single-center experience.
Sari S; Oguz D; Sucak T; Dalgic B; Atasever T
Dig Dis Sci; 2012 Jan; 57(1):175-81. PubMed ID: 21792618
[TBL] [Abstract][Full Text] [Related]
20. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension.
Chiva T; Ripoll C; Sarnago F; Rincón D; Gómez-Camarero J; Galindo E; Catalina MV; Elizaga J; Bañares R
Liver Int; 2015 Feb; 35(2):353-61. PubMed ID: 24797536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
